Ligand id: 6391

Name: bortezomib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 8
Hydrogen bond donors 4
Rotatable bonds 11
Topological polar surface area 124.44
Molecular weight 384.2
XLogP 1.01
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

1. Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A et al.. (2015)
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Ann. Rheum. Dis., 74 (7): 1474-8. [PMID:25710470]
2. Bonvini P, Zorzi E, Basso G, Rosolen A. (2007)
Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma.
Leukemia, 21 (4): 838-42. [PMID:17268529]
3. Ciechanover A. (2005)
Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture).
Angew. Chem. Int. Ed. Engl., 44 (37): 5944-67. [PMID:16142822]
4. Groll M, Berkers CR, Ploegh HL, Ovaa H. (2006)
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.
Structure, 14 (3): 451-6. [PMID:16531229]
5. Jakez-Ocampo J, Atisha-Fregoso Y, Llorente L. (2015)
Refractory primary Sjögren syndrome successfully treated with bortezomib.
J Clin Rheumatol, 21 (1): 31-2. [PMID:25539431]
6. Mazepa MA, Raval JS, Moll S, Ma A, Park YA. (2014)
Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
Br. J. Haematol., 164 (6): 900-2. [PMID:24345005]
7. Nakamura H, Watanabe M, Ban HS, Nabeyama W, Asai A. (2009)
Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors.
Bioorg. Med. Chem. Lett., 19 (12): 3220-4. [PMID:19428245]
8. Wang Y, Zhou W, Zhang Z. (2015)
Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient.
Rheumatology (Oxford), 54 (1): 194-5. [PMID:25288787]
9. Zhang H, Liu Z, Huang L, Hou J, Zhou M, Huang X, Hu W, Liu Z. (2017)
The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis.
Lupus, 26 (9): 952-958. [PMID:28059023]